Upstream stimulatory factor 2 inhibits erastin-induced ferroptosis in pancreatic cancer through transcriptional regulation of pyruvate kinase M2
Authors:
- 19 September 2022
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 205, 115255
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81761148029)
This publication has 49 references indexed in Scilit:
- Activation of Akt protects cancer cells from growth inhibition induced by PKM2 knockdownCell & Bioscience, 2014
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- Iron and cancer: more ore to be minedNature Reviews Cancer, 2013
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Pancreatic cancerThe Lancet, 2011
- Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1Cell, 2011
- Tumor-suppression function of transcription factor USF2 in prostate carcinogenesisOncogene, 2005
- IRON, FERRITIN, AND NUTRITIONAnnual Review of Nutrition, 2004
- Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammationBlood, 2003
- Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 ( USF2 ) knockout miceProceedings of the National Academy of Sciences, 2001